10,000 volunteers needed to uncover hidden liver disease risks
NCT ID NCT07336563
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will screen up to 10,000 adults aged 18-75 who are overweight or have metabolic issues like high blood sugar or cholesterol. Researchers will use questionnaires, blood tests, and liver ultrasounds to find out how common fatty liver disease is and what factors increase risk. The goal is to build a detailed database to improve future diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify who is at risk for fatty liver disease and guide future prevention or treatment trials.
- What could go wrong
- This is an observational screening study, not a treatment trial. It collects data only and does not test any therapy, so direct patient benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ENDOCARE
Wroclaw, 50-558, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- Ancient herb huangjing put to the test against hidden belly fat
- Can a common diabetes drug reshape PCOS metabolism?
- Lifestyle overhaul may restore penile blood flow in metabolic syndrome
- Fiber gummies: a tasty new weapon against obesity?